"The CIOMS Guide to Vaccine Safety Communication provides an overview of strategic communication issues faced by medicines regulators, those responsible for vaccination policies and programmes and other stakeholders when dealing with:
- the launch of newly-developed vaccines for the first time to market,
- the introduction of current or underutilized vaccines into new countries, regions, or populations, and
- the handling of any new safety issue arising during the life-cycle of a vaccine"
- CIOMS Guide to Vaccine Safety Communication
Web link
Implementation Tool
Link
Audiovisual
0 Comments
Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.
All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.
You must login or register before you can submit a comment.